Ledermann JA, Coleman RL. The PARP inhibitor/Immunotherapy Paradox in Advanced Ovarian Cancer: Positive Endpoints, Perplexing Interpretations. Ann Oncol 2025 Dec 10:S0923-7534(25)06318-5. doi: 10.1016/j.annonc.2025.
PMID: 41386294